Dark

CNTX
Context Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Aug 4, 2026 3:59:35 PM EDT

0.6200USD+2.748%(+0.0166)945,358

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Aug 4, 2026 9:25:30 AM EDT

0.5999USD-0.695%(-0.0042)16,665

After-hours

Aug 4, 2026 4:54:30 PM EDT

0.6387USD+2.900%(+0.0180)83,557

Overview HistoricalExchangesShortsMore

open chart

Market Cap

56.98M

Headquarters

Philadelphia, Pennsylvania, USA

Industry

Biotechnology

Next Earnings

Aug 5, 2026 (today)

CNTX Stats

Avg. Vol. 10 Day

1,504,137

Avg. Vol. 30 Day

2,979,723

Market Cap

56,983,466

Shares Out.

91,879,177

On/Off Exchange

42%/58%

6 Month Beta

-0.11

1 Year Beta

0.15

2 Year Beta

0.77

3 Year Beta

0.76

52 Week Low

0.55

52 Week High

3.62

SMA50

1.12

SMA200

1.73

1 Week

+5.01%

1 Month

-2.73%

3 Month

-73.04%

6 Month

-73.04%

1 Year

-8.79%

2 Year

-72.06%

5 Year

-87.84%

Profile

context therapeutics is dedicated to discovering, acquiring, and developing novel compounds to treat hormone responsive cancers. our lead program is apristor (onapristone xr), an investigational drug for progesterone receptor positive (pr+) breast cancer. up to 70% of breast cancers express progesterone receptor (pr). if your cancer is pr+, apristor could be an option for you.

CNTX Stock Summary

Context Therapeutics Inc. Common Stock (NASDAQ:CNTX) stock price today is $0.6200, and today's volume is 945,358. CNTX is up 2.748% today. The 30 day average volume is 2,979,723. CNTX market cap is 56.98M with 91,879,177 shares outstanding.

.dark-mode .PJ3NHC{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .PJ3NHC{ color: #333333; background-color: white; border: 2px solid #333333; }CNTXContext Therapeutics Inc. Common Stockstock NASDAQ

CNTX Stock Summary

CNTX
Context Therapeutics Inc. Common Stock
stock NASDAQ